Critical

Acute pulmonary oedema in pregnancy

Cardiorespiratory · Obstetric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Cardiogenic or non-cardiogenic pulmonary oedema in pregnancy from cardiac disease, severe pre-eclampsia, fluid overload or tocolytic therapy. Presents with acute breathlessness, hypoxia and pink frothy sputum.

Red flags

  • Severe hypoxia/respiratory failure
  • Hypotension/cardiogenic shock
  • Fetal distress
  • Reduced consciousness

Assessment

Differential diagnosis

  • Pulmonary embolism
  • Pneumonia/ARDS
  • Amniotic fluid embolism
  • Peripartum cardiomyopathy
  • Severe pre-eclampsia

Investigations

  • ABG/SpO2, chest X-ray
  • ECG and troponin
  • Echocardiography
  • BNP, U&E, FBC
  • Pre-eclampsia screen and fetal monitoring

Management

  • Sit upright, high-flow oxygen; consider CPAP/NIV
  • IV access and cardiac monitoring; left lateral positioning if late pregnancy
  • IV loop diuretic and treat hypertension (especially in pre-eclampsia)
  • Restrict fluids and stop any offending tocolytic
  • Identify cause (cardiac, pre-eclampsia, iatrogenic)
  • Involve obstetrics, cardiology and critical care; plan delivery if maternal compromise

Drugs & doses

Oxygen +/- CPAP
IV furosemide
IV antihypertensives (e.g. labetalol/hydralazine) for pre-eclampsia
Nitrates for cardiogenic oedema with adequate BP
Magnesium sulfate for pre-eclampsia/eclampsia

Disposition

Admit to HDU/ICU with obstetric and cardiology involvement.

Complications & pitfalls

  • Respiratory failure
  • Cardiac arrest
  • Fetal compromise

Exam pearls

  • Stop beta-agonist tocolytics if implicated
  • In severe pre-eclampsia, control BP and restrict fluids
  • Peripartum cardiomyopathy may present this way postnatally

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.